Proteogenomic and metabolomic characterization of human glioblastoma

Cited by (656)

Items 401–500 of 656

1. Nanomedicine-enabled epigenetic therapy for glioblastoma: Overcome the blood-brain barrier and therapeutic resistance
   Qingxin Yang, Yuan Zhong, Shaoyu Cai, Zenghua Sheng, Da Sun, Peixing Chen, Yuanyuan Zhang, Jianshu Li, Wei Wu, Maolan Zhang · 2026 · Nano Research
2. Emerging roles of ferroptosis in modulating the immune landscape of glial tumours
   Michael Argenziano, Taruna V. Neelakantan, Colin P. Sperring, Oluwaseyi O. Adeuyan, Dominique M. O. Higgins, Jeffrey N. Bruce, Betty Y.S. Kim, Athanassios Dovas, Peter Canoll, Michael K. Lim et al. · 2026 · Nature Cell Biology
3. Evaluation of machine learning models on protein level inference from prioritized RNA features
   Wenjian Xu, Haochen He, Zhengguang Guo, Wěi Li · 2022 · Briefings in Bioinformatics
4. A proteome-level view of brain tumors for a better understanding of novel diagnosis, prognosis, and therapy
   Medha Gayathri J. Pai, Deeptarup Biswas, Ayushi Verma, Sanjeeva Srivastava · 2023 · Expert Review of Proteomics
5. ENPP1 inhibits the transcription activity of the hepatitis B virus pregenomic promoter by upregulating the acetylation of LMNB1
   Xinping Ma, Yuan Li, Huihui Zhu, Kai Lǚ, Yingli Huang, Xiaofang Li, Shuangyin Han, Hui Ding, S. Sun · 2024 · Archives of Virology
6. Proteomic features of soft tissue tumours in adolescents and young adults
   Yuen Bun Tam, Kaan Low, Hari PS, Madhumeeta Chadha, Jessica Burns, Christopher P. Wilding, Amani Arthur, Tom Wei‐Wu Chen, Khin Thway, Anguraj Sadanandam et al. · 2024 · Communications Medicine
7. Network‐Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma
   Pablo Shimaoka Chagas, Henrique Izumi Shimaoka Chagas, Sahar Emami Naeini, Bidhan Bhandari, Jules Gouron, Tathiane Maistro Malta, Évila Lopes Salles, Lei P. Wang, Jack Chung-Kai Yu, Babak Baban · 2024 · Journal of Cellular Biochemistry
8. Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
   Anqi Zhang, Ting Sun, Dandan Yu, Rongfeng Fu, Xiao Fan Liu, Xue Feng, Wei Liu, Mankai Ju, Xinyue Dai, Huan Dong et al. · 2024 · Clinical and Experimental Medicine
9. Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types
   Zhongyan Li, Jingting Wan, Shangfu Li, Yun Tang, Yang-Chi-Dung Lin, Jie Ni, Xiaoxuan Cai, Jinhan Yu, Hsien‐Da Huang, Tzong-Yi Lee · 2024 · International Journal of Molecular Sciences
10. Mass Spectrometry Advances in Analysis of Glioblastoma
    Sofian Al Shboul, Ashita Singh, Renata Kobetić, David R. Goodlett, Paul Martin Brennan, Ted R. Hupp, Irena Đapić · 2024 · Mass Spectrometry Reviews
11. Decoding Ubiquitin Modifications by Mass Spectrometry
    Yanqiu Gong, Lunzhi Dai · 2024 · Advances in experimental medicine and biology
12. Understanding the Immune System and Biospecimen-Based Response in Glioblastoma: A Practical Guide to Utilizing Signal Redundancy for Biomarker and Immune Signature Discovery
    Luke R. Jackson, Anna Erickson, Kevin A. Camphausen, Andra Valentina Krauze · 2024 · Current Oncology
13. Advancements in proteogenomics for preclinical targeted cancer therapy research
    Yuying Suo, Yuanli Song, Yuqiu Wang, Qian Liu, Henry Rodriguez, Hu Zhou · 2025 · Biophysics Reports
14. Roles and Impacts of Integrative Medical Interventions in Central Nervous System Tumor Treatment: Multi‐Technology Convergence and the Paradigm Shift Toward Functional Reconstruction
    Junda Lai, Ketao Liu, Yichao Lin, Zhonglin Chen, Xinna Ji, Junkai Wen · 2025 · CNS Neuroscience & Therapeutics
15. Neurooncology: 2022 update
    Pieter Wesseling, Jacob S Rozowsky · 2022 · Free Neuropathology
16. Complex Disease Genes Identification Using a Heterogeneous Network Embedding Approach
    Mahdieh Ghasemi, Maseud Rahgozar, Kaveh Kavousi · 2022 · IEEE Transactions on Computational Biology and Bioinformatics
17. Screening MT1-MMP Activity and Inhibition in Three-Dimensional Tumor Spheroids
    Anna M. Knapinska, Gary Drotleff, Cedric Chai, Destiny Twohill, Alexa Ernce, Dorota Tokmina‐Roszyk, Isabella Grande, Michelle Rodriguez, Brad Larson, Gregg B. Fields · 2023 · Biomedicines
18. Untangling the web of glioblastoma treatment resistance using a multi-omic and multidisciplinary approach
    Donald Max Miller, Kavitha Yadanapudi, Veeresh Rai, Shesh Nath Rai, Joseph Chen, Hermann B. Frieboes, Adrianna Henson Masters, Abigail P. McCallum, Brian J. Williams · 2023 · The American Journal of the Medical Sciences
19. TMT‐Based Quantitative Proteomic Profiling of Human Esophageal Cancer Cells Reveals the Potential Mechanism and Potential Therapeutic Targets Associated With Radioresistance
    Aidi Gao, Chao sheng He, Hengrui Chen, Qianlin Liu, Yin Chen, Jianying Sun, Chuanfeng Wu, Ya Pan, Sónia Rocha, Mu Wang et al. · 2024 · PROTEOMICS - CLINICAL APPLICATIONS
20. Transcriptomic analysis of EGFR co-expression and activation in glioblastoma reveals associations with its ligands
    Santoesha A. Ghisai, Nastaran Barin, Levi van Hijfte, Kim Verhagen, Maurice de Wit, Martin J. van den Bent, Youri Hoogstrate, Pim J. French · 2024 · Neuro-Oncology Advances
21. Sex differences in the cancer proteome
    Chenghao Zhu, Nicole Zeltser, Jieun Oh, Constance H. Li, Paul Christopher Boutros · 2026 · BMJ Oncology
22. Online Tools for Teaching Cancer Bioinformatics
    Mason D. Taylor, Bryn Mendenhall, Calvin S. Woods, Madeline E. Rasband, Milene C. Vallejo, Elizabeth Gibbons Bailey, Samuel Payne · 2021 · Journal of Microbiology and Biology Education
23. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Radix Paeoniae Rubra Against Glioma
    Siyu Zhu, Qianxu Jin, Shiyang Zhang, Zihan Song, Shiqi Zhang, Zongmao Zhao · 2024 · Applied Biochemistry and Biotechnology
24. Enhancing Biomedicine: Proteomics and Metabolomics in Action
    Michele Costanzo, Marianna Caterino, Lucia Santorelli · 2025 · Proteomes
25. A Dot-Blot Screening for Identifying the Temozolomide-Regulated Proteins as Potential Targets for Glioma Multi-OMICS Studies
    Anna Bielecka, Grzegorz Machnik, Christina Linnebacher, Michael Linnebacher, Katarzyna Stec-Grosman, Ewa Obuchowicz · 2024 · Frontiers in Bioscience-Landmark
26. Prognostic signature detects homologous recombination deficient in glioblastoma
    Dongdong Luo, Aiping Luo, Su Hu, Hailin Zhao, Xuefeng Yao, Dan Li, Biao Peng · 2024 · Translational Cancer Research
27. Identification of SURF4 and RALGAPA1 as promising therapeutic targets in glioblastoma and pan-cancer through integrative multi-omics, CRISPR-Cas9 screening and prognostic meta-analysis
    Fei Wang, Yuxuan Chen, Run Huang, Dengfeng Lu, Juyi Zhang, Yanbo Yang, Hanhan Dang, Meirong Liu, Zhouqing Chen, Xiaoou Sun et al. · 2025 · Cancer Immunology Immunotherapy
28. Cerebral open flow microperfusion (cOFM)-HILIC-HRMS platform for in vivo and in situ monitoring of tumor microenvironment in glioblastoma
    Fernanda Monedeiro, Denise Schimek, Eva-Maria Prugger, Thomas Altendorfer‐Kroath, Elmar Zügner, Christoph Magnes · 2025 · Analytica Chimica Acta
29. Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures
    Yuji Matsumoto, Omkar Singh, José García, Zied Abdullaev, Nelson F. Freeburg, Fanyang Yu, Hamed Akbari, K. H. Baik, Jun Guo, Natalie N. C. Shih et al. · 2025 · Neuro-Oncology
30. Toward real clinical utility: leveraging comprehensive cancer proteomic datasets for clinical insight
    Karin Rodland, Bing Zhang · 2025 · Expert Review of Proteomics
31. Metabolic profiling defines glioblastoma subtypes with distinct prognoses and therapeutic vulnerabilities
    Fan Wu, Yiyun Yin, Di Wang, Chang-Qing Pan, You Zhai, Mingchen Yu, Z Wang, Wen-Hua Fan, Zheng Zhao, Guan-Zhang Li et al. · 2025 · Neuro-Oncology
32. OmNI: a modular open-source framework for interactive multi-omics data integration and visualization
    Grace Potter, Jacob A. Beierle, Camron D. Bryant, Sadhna Phanse, C. R. White, Andrew Emili, Indranil Paul · 2025 · NAR Genomics and Bioinformatics
33. CDK1-driven phosphorylation networks promote glioblastoma progression via MAP1B-mediated microtubule destabilization
    Jun-Tao Li, Mengda Li, Yong-Ji Guo, Zhi-Xiao Li, Rongjun Qian, Chunxiao Ma · 2026 · Frontiers in Oncology
34. Lipid metabolism classification of gliomas
    Shaohua Tu, Peng Zhang, Xiaohan Chi, Yang Zhang, Nan Ji · 2026 · Scientific Reports
35. Omics-based profiling of immune cell death in autoimmunity and inflammation
    Sailee Chowdhury, Sithi Sarkar, Anirban Das, Koyel Kar, Priyanka Chakraborty · 2026 · Cell Death
36. Global impact of germline structural variation on the cancer proteome
    Fengju Chen, Yiqun Zhang, Luis F. Paulin, Darshan Shimoga Chandrashekar, Sooryanarayana Varambally, Fritz Joachim Sedlazeck, Chad J. Creighton · 2026 · Nature Communications
37. KATP Channel Expression Determines ONC212 Sensitivity via Mitochondrial Dysfunction and PERK / ATF4 / CHOP Activation in Glioblastoma
    Ahmet Taskesen, Ceyhan Hacıoğlu · 2026 · Journal of Cellular and Molecular Medicine
38. PCLassoLog: A protein complex-based, group Lasso-logistic model for cancer classification and risk protein complex discovery
    Wei Wang, Haiyan Yuan, Junwei Han, Wei Liu · 2022 · Computational and Structural Biotechnology Journal
39. Dysregulated ceramides metabolism via PTPN11 exposes a metabolic vulnerability to breast cancer metastasis
    Sen Qiao, Tianwei Wang, Hongmei Wang · 2023 · Medical Oncology
40. The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma
    Huatao Niu, Honghua Cao, Xin Liu, Yanbei Chen, Zhaojin Cheng, Jinyong Long, Fuhua Li, Chaoyan Sun, Pin Zuo · 2024 · American Journal of Clinical Oncology
41. A platform-independent AI tumor lineage and site (ATLAS) classifier
    Nicholas Robert Rydzewski, Yue Shi, Chenxuan Li, Matthew R. Chrostek, Hamza Bakhtiar, Kyle T. Helzer, Matthew L. Bootsma, Tracy J. Berg, Paul M. Harari, John M. Floberg et al. · 2024 · Communications Biology
42. Integrated microRNA and proteome analysis of cancer datasets with MoPC
    Marta Lovino, Elisa Ficarra, Loredana Martignetti · 2024 · PLoS ONE
43. CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study
    Andrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, Cristina Bottin, Maurizio Pinamonti, Benvenuto Ferrari, Francesco Schettini, Estela Pineda, Stefano Panni, Marika Cominetti et al. · 2024 · Cells
44. Organoids as a model system for researching human neuroendocrine tumor of the breast
    Dongyi Zhao, Xue Bai, Shida Zhu, Zuowei Zhao, Xuelu Li · 2024 · Cancer Cell International
45. Protocol for tandem enrichment of ubiquitinated, phosphorylated, and glycosylated peptides with SCASP-PTM
    Zhan-Peng Lin, Yuyang Wang, Chengwen Wen, Kaijie Zhang, Xiangyu Chen, Liang Xu, Wan-Yue Luo, Changchuan Xie, Chuan‐Qi Zhong · 2025 · STAR Protocols
46. Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma
    Sojin Kim, Soo-Ji Park, Tamrin Chowdhury, Jeong-Im Hong, Jinhee Ahn, Tae Yeong Jeong, Hyeon Jong Yu, Young‐Kyoung Shin, Ja‐Lok Ku, Jong Bae Park et al. · 2022 · Cellular and Molecular Life Sciences
47. Metabolomic characterization of congenital microtia: a possible analysis for early diagnosis
    Suijun Chen, Huasong Zhang, Xueping Huang, Wenhui Li, Yue Liu, Cong Fan, Feiyi Liu, Huiying Zhao, Yi-Qing Zheng · 2022 · Annals of Translational Medicine
48. Investigation of cystine as differential diagnostic biomarker between astrocytomas and oligodendrogliomas based on global- and targeted analysis using liquid chromatography/tandem mass spectrometric analysis
    Masahiro Watanabe, Masamitsu Maekawa, Masayuki Kanamori, Minami Yamauchi, Ai Abe, Yoshiteru Shimoda, Ryuta Saito, Hidenori Endo, Nariyasu Mano · 2023 · Advances in Biomarker Sciences and Technology
49. Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas
    Avaniyapuram Kannan Murugan, Siddarth Kannan, Ali Saeed Alzahrani · 2025 · Current Problems in Cancer
50. Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions
    Brandon Bumbaca, Jonah R. Huggins, Marc R. Birtwistle, James M. Gallo · 2025 · npj Systems Biology and Applications
51. Integrated 4D label-free proteome and SUMOylated proteome in glioma uncover novel pathological mechanisms and pave the way for precision therapy
    Jiazheng Wang, Zhuo Li, Kaijie Mu, Qichao Qi, Zeli Zhang, Can Yan, Xukai Jiang, Anjing Chen · 2025 · Cell Insight
52. Using the metabolite alterations monitoring the AEG-1 expression level and cell biological behaviour of U251 cell in vitro
    Yurui Sheng, Di Yin, Qingshi Zeng · 2023 · PLoS ONE
53. Proteogenomics Reveal the Overexpression of HLA-I in Cancer
    Ying Wang, David Fenyö · 2023 · Journal of Proteome Research
54. Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry
    Jeffrey R. Whiteaker, Lei Zhao, Regine M. Schoenherr, Dongqing Huang, Jacob J. Kennedy, Richard G. Ivey, Chenwei Lin, Travis D. Lorentzen, Simona Colantonio, Tessa W. Caceres et al. · 2024 · Scientific Data
55. A Review on Placemaking Strategies Towards Enhancing “Sense of Place” in Parks
    Adhesh, Shanta Pragyan Dash, K. Rajalaxmi, Swara Ramesh Nayak · 2024 · Lecture notes in civil engineering
56. A study of RNA splicing and protein expression in the living human brain
    Brian Harris Kopell, Deepak A. Kaji, Lora E. Liharska, Eric Vornholt, Anina N. Lund, Alice Hashemi, Ryan C. Thompson, Jessica Johnson, Nicole Bussola, Esther Cheng et al. · 2025 · PLoS ONE
57. SpecQuality: A Tool for Reliable Spectral Quality Assessment in Proteomics and Proteogenomics
    Alka Yadav, Uma Dhawan · 2025 · Journal of the American Society for Mass Spectrometry
58. ProteoformDB: A Built-in Application to Generate Proteoform Database
    Trung Hoàng, Ying Hu, Hui Zhang · 2025 · Journal of Proteome Research
59. Multi-Modal Metabolomics Deciphers Pan-Cancer Metabolic Landscapes and Spatial-Niche-Specific Alternations
    Tingze Feng, Hai‐long Piao, Di Chen · 2026 · Metabolites
60. Plasma metabolomic signatures of all and cause-specific cancers: a multi-platform population-based study
    Yu Shuai, Rikje Ruiter, Bruno H. Ch. Stricker, M. Arfan Ikram, Mohsen Ghanbari · 2026 · Metabolomics
61. Pan-Cancer Proteomic and Transcriptomic Meta-Analysis of PD-1/PD-L1 Signaling Reveals Predictive Biomarkers for Anti-PD-1 Therapy in Lung Cancer.
    Yu-Ying Suo, Yuanli Song, Hu Zhou, Qian Liu · 2026 · Journal of Proteome Research
62. Region-Resolved Integrative Multi-Omic Characterization Reveals Diverse Tumor and Microenvironment Features of Pituitary Neuroendocrine Tumors
    Tao Xie, Qiang Xie, Qin Hu, Jiamin Hu, Gao Y, Rongkui Luo, Chaolong Yan, Pin Chen, Zijiang Yang, Yi Liu et al. · 2026 · Molecular & Cellular Proteomics
63. Towards deciphering glioblastoma intra‐tumoral heterogeneity: The importance of integrating multidimensional models
    Rifat Shahriar Sajid, Lennart J. van Winden, Phedias Diamandis · 2023 · PROTEOMICS
64. What single-cell RNA sequencing taught us about MGMT expression in glioblastoma
    Iyad Alnahhas, Marium Nadeem Khan, Wenyin Shi · 2025 · Neuro-Oncology Advances
65. Inferring kinase–phosphosite regulation from phosphoproteome-enriched cancer multi-omics datasets
    Haoyang Cheng, Zhuoran Liang, Yijin Wu, Jiamin Hu, Bijin Cao, Zekun Liu, Bo Liu, Han Cheng, Zexian Liu · 2025 · Briefings in Bioinformatics
66. Adult diffuse IDH-wildtype lower-grade gliomas with PDGFRA gain/amplification should be upgraded as glioblastoma
    Yue Li, Xiujiao Shen, Ji Zhang, Xinyi Xian, Shaoyu Chen, Jing Zeng, Wanming Hu · 2025 · Journal of Neuropathology & Experimental Neurology
67. Determination of ADP / ATP translocase isoform ratios in malignancy and cellular senescence
    Zuzana Liblova, Dominika Maurencova, Barbora Šalovská, Marek Kratky, Tomáš Mráček, Zuzana Korandová, Alena Pecinová, Pavla Vašicová, David Rysanek, Ladislav Anděra et al. · 2025 · Molecular Oncology
68. MRI-based machine learning reveals proteasome subunit PSMB8-mediated malignant glioma phenotypes through activating TGFBR1/2-SMAD2/3 axis
    Dongling Pei, Zeyu Ma, Yuning Qiu, Minkai Wang, Zilong Wang, Xianzhi Liu, Long Zhang, Zhenyu Zhang, Ran Li, Dongming Yan · 2025 · Molecular Biomedicine
69. ProgModule: A novel computational framework to identify mutation driver modules for predicting cancer prognosis and immunotherapy response
    Xiangmei Li, Bingyue Pan, Xilong Zhao, Yinchun Su, Jiyin Lai, Siyuan Li, Yalan He, Jiashuo Wu, Junwei Han · 2025 · Journal of Translational Medicine
70. LTF regulates glioblastoma progression and temozolomide resistance via the NF-κB signaling pathway
    Lili Gao, Hongbo Xiao, Hongyu Lu, Jun Ma, Haifeng Zhu · 2025 · Brazilian Journal of Medical and Biological Research
71. Bioinspired fibrin hydrogel loading nanoparticles targets postoperative residual lesion for glioblastoma therapy
    Xiao Zhao, Hexuan Wang, Yifei Chi, Wenru Shen, Xiaoyun Lu, Jingbo Wu, Zhiwen Zhang · 2025 · Chinese Chemical Letters
72. Histone H3K4/H3K9 Methylation Dynamics Gate Cell Fate Plasticity in Pediatric High-Grade Gliomas: A Systems-Level Attractor Reconstruction
    Abicumaran Uthamacumaran · 2025 · Journal of Computational Biophysics and Chemistry
73. Integrative multi-omics analysis proposes a metabolic classification of gliomas: distinct metabolic states, immune infiltration, and prognosis
    Qiang Zhu, Wanxiang Niu, Maolin Mu, Chengkun Ye, Chaoshi Niu · 2025 · Journal of Translational Medicine
74. From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy Selection
    Ekaterina E. Sleptsova, Olga Vershinina, Mikhail Ivanchenko, Victoria D. Turubanova · 2026 · International Journal of Molecular Sciences
75. Panorama: a database for the oncogenic evaluation of somatic mutations in pan-cancer
    Seung-Jin Park, Seon‐Young Kim · 2026 · Database
76. Identification of Tumor- and Immunosuppression-Driven Glioblastoma Subtypes Characterized by Clinical Prognosis and Therapeutic Targets
    Pei Zhang, Dan Liu, Xiaoyu Liu, Shuai Fan, Yuxin Chen, Tonghui Yu, Lei Dong · 2026 · Current Issues in Molecular Biology
77. ProteoBoostR: an interactive framework for supervised machine learning in clinical proteomics
    Annika Topitsch, Niko Pinter, Tilman Werner, Katja Nelson, Tobias Fretwurst, Oliver Schilling · 2026 · Clinical Proteomics
78. Repositioning HDAC Inhibitors for Glioma Treatment: Synthesis and Biological Evaluation
    Luciana Costa Furtado, Karoline B. Waitman, Nuno A. T. F. Silva, Leticia Marcelino Gouvea, Thales Kronenberger, Mônica F. Z. J. Toledo, Elthon Gois Ferreira, João Agostinho Machado‐Neto, Frank A.E. Kruyt, Roberto Parise‐Filho et al. · 2026 · ACS Omega
79. Rare germline variants contribute to glioma predisposition: Whole-genome analysis of a regional cohort of glioma patients
    Adam Rosenbaum, Carl Wibom, Austin Hammermeister Suger, Raphaela Pensch, Ananya Roy, Thomas Brännström, Matilda Rentoft, Karin Forsberg‐Nilsson, Kerstin Lindblad‐Toh, Sara Lindström et al. · 2026 · Neuro-Oncology Advances
80. Associations of Normalization and Regularization with Machine Learning Overfitting in Cross-dataset Classification of Deaths Using Transcriptomic and Clinical Data: A Secondary Analysis of Publicly Available Databases
    Fei Deng, Lanjing Zhang · 2026 · Journal of Clinical and Translational Pathology
81. PDS5A and TOP2B cooperate for chromatin recruitment via CTCF
    Edgar González-Buendía, Havva Ortabozkoyun, Danny Reinberg · 2026 · Science Advances
82. Deciphering the multi-site phos-code of IRBIT underlying its binding to IP3R
    Qing Lin, Hao Yang, Qi Feng, Tomohide Sumi, Kozo Hamada, Yi Qian, Fang Bai, Akihiro Mizutani, Katsuhiko Mikoshiba · 2026 · Communications Biology
83. Understanding resistance in glioblastoma: insights into personalized and targeted therapeutic strategies
    Nourhan E. Omran, Ruba A. Zenati, Lara J. Bou Malhab, Yasser Bustanji, Karem Hasan Alzoubi, Rania Harati, Mohammad H. Semreen · 2026 · Neuroscience
84. Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease
    Matthew Muller, MacIntosh Cornwell, Sandhya Rajkumar, Ze Chen, David Coit, Gabin Drouard, Paul Sastourne-Haletou, Huan Yang, Olli Tuomas Raitakari, Terho J. Lehtimäki et al. · 2026 · Nature Communications
85. Amino Acid Substitutomics: Profiling Amino Acid Substitutions at the Proteomic Scale Unveils Biological Implications and Escape Hypotheses in Cancer
    Peize Zhao, Shengzhi Lai, Shuaijian Dai, Chen Zhou, Ning Li, Weichuan Yu · 2026 · Journal of Proteome Research
86. Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growth
    Kalil G. Abdullah, Kenji Miki, Charles K. Edgar, Shuangcheng Alivia Wu, Yi Xiao, Yuan-Tai Huang, Richard Drexler, Saritha Krishna, Vineshkumar Thidil Puliyappadamba, Li Wei Rachel Tay et al. · 2026 · Cell
87. Prognosis-correlated Systems Involving Characteristic Diagnostic Gene Sets for Survival Analysis on Glioma
    Junwei Li, Tingting Zhou, Chenyou Sun, Peng Zhou · 2022 · Journal of Molecular Neuroscience
88. Master kinases extracted from proteogenomic networks in glioblastoma drive cancer subtypes
    2023 · Nature Cancer
89. Statistical and Computational Methods for Proteogenomic Data Analysis
    Xiaoyu Song · 2023 · Methods in molecular biology
90. PhosMap: An ensemble bioinformatic platform to empower interactive analysis of quantitative phosphoproteomics
    Mengsha Tong, Zan Liu, Jiaao Li, Xin Lan Wei, Wenhao Shi, Chenyu Liang, Chunyu Yu, Rongting Huang, Yuxiang Lin, Xinkang Wang et al. · 2024 · Computers in Biology and Medicine
91. Identification of potential biomarkers in glioblastoma through omics technologies and big data analysis
    Ayushi Verma, Ankit Halder, Prasoon Prakash, Sanjeeva Srivastava · 2023 · Elsevier eBooks
92. Fam20C Kinase as a Key Regulator of Bevacizumab Resistance in Mesenchymal Glioblastoma
    Chan Il Kim, Sooheon Kim, Seong‐Min Park, Sung Soo Kim, Hyung Joon Kwon, Weiwei Lin, Saewhan Park, Seokjun Ha, Kyung Hee Ha, Sanha Park et al. · 2023 · Advanced Therapeutics
93. Glioblastoma Subtypes Exhibit Distinct Migration Mechanics and Immune Responses
    Ghaidan A. Shamsan, Chao J. Liu, Brooke C. Braman, Ruyi Li, Susan K. Rathe, Aaron L. Sarver, Nima Ghaderi, Mariah M. McMahon, Rebecca L. Klank, Barbara R. Tschida et al. · 2026 · Cancer Research Communications
94. Letter to the Editor Regarding “5-Aminolevulinic Acid False Positives in Cerebral Neuro-Oncology: Not All That Is Fluorescent Is Tumor. A Case-Based Update and Literature Review”
    Susanna Mandruzzato, Alessandro Della Puppa · 2022 · World Neurosurgery
95. KBPRNA: A novel method integrating bulk RNA-seq data and LINCS-L1000 gene signatures to predict kinase activity based on machine learning
    Yuntian Zhang, Lantian Yao, Yixian Huang, Wenyang Zhang, Yuxuan Pang, Tzongyi Lee · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
96. Proteomic profiling of IDH-wildtype Glioblastoma Tissue and Serum uncovers prognostic Subtypes and Marker Candidates
    Tilman Werner, Agnes Schäfer, Michael Hennes, Miguel Cosenza‐Contreras, Guadalupe Espadas, Eduard Sabidó, Lena Cook, Axel Pagenstecher, Niko Pinter, Tobias Feilen et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
97. Multiomic foundations of human prefrontal cortex tissue function
    Brian Harris Kopell, Deepak A. Kaji, Lora E. Liharska, Eric Vornholt, Alissa A. Valentine, Anina N. Lund, Alice Hashemi, Ryan C. Thompson, Terry M. Lohrenz, Jessica Johnson et al. · 2024 · medRxiv
98. Utilizing proteomics and phosphoproteomics to predict ex vivo drug sensitivity across genetically diverse AML patients
    Sara J.C. Gosline, Cristina E. Tognon, Michael D. Nestor, Sunil Kumar Joshi, Rucha V. Modak, Alisa Damnernsawad, Jamie Moon, Joshua Hansen, Chelsea M. Hutchinson-Bunch, Marina A. Gritsenko et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
99. Optimized Data-Independent Acquisition Approach for Proteomic Analysis at Single-Cell Level
    Yuefan Wang, T. Mamie Lih, Lijun Chen, Yuanwei Xu, Morgan D. Kuczler, Liwei Cao, Kenneth J. Pienta, Sarah R. Amend, Hui Zhang · 2021 · Research Square
100. Optimized Data-Independent Acquisition Approach for Proteomic Analysis at Single-Cell Level
     Yuefan Wang, T. Mamie Lih, Lijun Chen, Yuanwei Xu, Morgan D. Kuczler, Liwei Cao, Kenneth J. Pienta, Sarah R. Amend, Hui Zhang · 2021 · Research Square